Dr. Jonathan D. Fish
Claim this profileThe Steven and Alexandra Cohen Children's Medical Center of New York
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
6 reported clinical trials
19 drugs studied
Area of expertise
1Leukemia
Stage II
Stage I
2Lymphoblastic Leukemia-Lymphoma
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Jonathan D. Fish is currently running
IST + BMT
for Aplastic Anemia
Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a matched sibling (brother or sister), or family donor is a bone marrow transplant. Patients without a matched family donor normally are treated with immune suppressive therapy (IST). Match unrelated donor (URD) bone marrow transplant (BMT) is used as a secondary treatment in patients who did not get better with IST, had their disease come back, or a new worse disease replaced it (like leukemia). This trial will compare time from randomization to failure of treatment or death from any cause of IST versus URD BMT when used as initial therapy to treat SAA. The trial will also assess whether health-related quality of life and early markers of fertility differ between those randomized to URD BMT or IST, as well as assess the presence of marrow failure-related genes and presence of gene mutations associated with MDS or leukemia and the change in gene signatures after treatment in both study arms. This study treatment does not include any investigational drugs. The medicines and procedures in this study are standard for treatment of SAA.
Recruiting2 awards Phase 3
Treosulfan-Based Conditioning
for Bone Marrow Failure
This trial tests if a combination of three drugs can reduce complications for patients with bone marrow failure diseases. The drugs work by killing harmful cells, stopping their growth, and reducing immune reactions.
Recruiting1 award Phase 211 criteria
More about Jonathan D. Fish
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jonathan D. Fish has experience with
- Cyclophosphamide
- Fludarabine
- Methotrexate
- Rabbit Anti-Thymocyte Globulin (ATG)
- Horse Anti-Thymocyte Globulin (ATG)
- Low-dose Total Body Irradiation (TBI)
Breakdown of trials Jonathan D. Fish has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Aplastic Anemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan D. Fish specialize in?
Jonathan D. Fish focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved Stage II patients, or patients who are Stage I.
Is Jonathan D. Fish currently recruiting for clinical trials?
Yes, Jonathan D. Fish is currently recruiting for 3 clinical trials in New Hyde Park New York. If you're interested in participating, you should apply.
Are there any treatments that Jonathan D. Fish has studied deeply?
Yes, Jonathan D. Fish has studied treatments such as Cyclophosphamide, Fludarabine, Methotrexate.
What is the best way to schedule an appointment with Jonathan D. Fish?
Apply for one of the trials that Jonathan D. Fish is conducting.
What is the office address of Jonathan D. Fish?
The office of Jonathan D. Fish is located at: The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York 11040 United States. This is the address for their practice at the The Steven and Alexandra Cohen Children's Medical Center of New York.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.